Remove Biopharma Remove Key account management Remove Medical science
article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Content automation will deliver as AI fails to live up to the hype.

Marketing 106